Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204238661> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3204238661 endingPage "11" @default.
- W3204238661 startingPage "5" @default.
- W3204238661 abstract "Fabry disease represents an X-linked inherited disorder resulting in the accumulation of globotriaosylceramide (Gb3). This review explains the clinical manifestations and the possible therapies for this condition. Fabry disease is considered the second most frequent lysosomal storage disease. More than 1000 mutations of the galactosidase alpha (GLA) gene associated with this disorder have been identified. Pain, either episodic crises or chronic pain, is one of the earliest symptoms in Fabry disease. Gastrointestinal, ocular, ear or skeletal manifestations may complete the clinical picture. Cardiac and renal involvements are the most severe complications leading to organ failure and death. The cerebrovascular lesions may result in severe symptoms including stroke at younger ages. The diagnosis of Fabry disease may be put by enzymatic assays of the α-galactosidase A (AGAL-A) activity in plasma or leukocytes but genetic analysis remains the gold standard in identifying the precise mutation and even guiding the treatment. Enzyme replacement therapy (ERT) was the first step in treating subjects with Fabry disease. It proved important decrease of the number of sever clinical events and reduction of symptoms. Chemical chaperone therapy has many advantages including oral administration and was already approved in Europe and US, but it is suitable only for subjects with amenable mutations. Gene therapies (either ex vivo or in vivo) promise to represent a new era for many disorders including Fabry disease, the preliminary data being encouraging. Although many steps were taken in understanding the pathogeny of Fabry disease, future research is needed especially in the field of therapeutic approaches." @default.
- W3204238661 created "2021-10-11" @default.
- W3204238661 creator A5052007798 @default.
- W3204238661 creator A5064147340 @default.
- W3204238661 date "2021-10-02" @default.
- W3204238661 modified "2023-10-12" @default.
- W3204238661 title "Fabry disease – current data and therapeutic approaches" @default.
- W3204238661 doi "https://doi.org/10.47162/rjme.62.1.01" @default.
- W3204238661 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8597377" @default.
- W3204238661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34609404" @default.
- W3204238661 hasPublicationYear "2021" @default.
- W3204238661 type Work @default.
- W3204238661 sameAs 3204238661 @default.
- W3204238661 citedByCount "4" @default.
- W3204238661 countsByYear W32042386612022 @default.
- W3204238661 countsByYear W32042386612023 @default.
- W3204238661 crossrefType "journal-article" @default.
- W3204238661 hasAuthorship W3204238661A5052007798 @default.
- W3204238661 hasAuthorship W3204238661A5064147340 @default.
- W3204238661 hasBestOaLocation W32042386611 @default.
- W3204238661 hasConcept C126322002 @default.
- W3204238661 hasConcept C142724271 @default.
- W3204238661 hasConcept C177713679 @default.
- W3204238661 hasConcept C2776788019 @default.
- W3204238661 hasConcept C2777404818 @default.
- W3204238661 hasConcept C2777687718 @default.
- W3204238661 hasConcept C2778264360 @default.
- W3204238661 hasConcept C2778908642 @default.
- W3204238661 hasConcept C2779134260 @default.
- W3204238661 hasConcept C2779969927 @default.
- W3204238661 hasConcept C2780673598 @default.
- W3204238661 hasConcept C2909637497 @default.
- W3204238661 hasConcept C60644358 @default.
- W3204238661 hasConcept C71924100 @default.
- W3204238661 hasConcept C86803240 @default.
- W3204238661 hasConceptScore W3204238661C126322002 @default.
- W3204238661 hasConceptScore W3204238661C142724271 @default.
- W3204238661 hasConceptScore W3204238661C177713679 @default.
- W3204238661 hasConceptScore W3204238661C2776788019 @default.
- W3204238661 hasConceptScore W3204238661C2777404818 @default.
- W3204238661 hasConceptScore W3204238661C2777687718 @default.
- W3204238661 hasConceptScore W3204238661C2778264360 @default.
- W3204238661 hasConceptScore W3204238661C2778908642 @default.
- W3204238661 hasConceptScore W3204238661C2779134260 @default.
- W3204238661 hasConceptScore W3204238661C2779969927 @default.
- W3204238661 hasConceptScore W3204238661C2780673598 @default.
- W3204238661 hasConceptScore W3204238661C2909637497 @default.
- W3204238661 hasConceptScore W3204238661C60644358 @default.
- W3204238661 hasConceptScore W3204238661C71924100 @default.
- W3204238661 hasConceptScore W3204238661C86803240 @default.
- W3204238661 hasIssue "1" @default.
- W3204238661 hasLocation W32042386611 @default.
- W3204238661 hasLocation W32042386612 @default.
- W3204238661 hasLocation W32042386613 @default.
- W3204238661 hasOpenAccess W3204238661 @default.
- W3204238661 hasPrimaryLocation W32042386611 @default.
- W3204238661 hasRelatedWork W192812615 @default.
- W3204238661 hasRelatedWork W1985768899 @default.
- W3204238661 hasRelatedWork W2012825594 @default.
- W3204238661 hasRelatedWork W2045380837 @default.
- W3204238661 hasRelatedWork W2067330669 @default.
- W3204238661 hasRelatedWork W2084201369 @default.
- W3204238661 hasRelatedWork W2149584682 @default.
- W3204238661 hasRelatedWork W3152508416 @default.
- W3204238661 hasRelatedWork W3193959027 @default.
- W3204238661 hasRelatedWork W3204238661 @default.
- W3204238661 hasVolume "62" @default.
- W3204238661 isParatext "false" @default.
- W3204238661 isRetracted "false" @default.
- W3204238661 magId "3204238661" @default.
- W3204238661 workType "article" @default.